NLRP3 and myasthenia gravis: Resveratrol can inhibit the NF-κB signaling pathway in MG, effectively reduce the expression of NF-κB/IL-1β/inflammasome NLRP3, and alleviate inflammatory responses (Qi et al., 2019; Zhao et al., 2018).